In line with their less aggressive behaviour, SEMA3A low tumours responded to all the treatments, yet gemcitabine monotherapy did not reach statistical significance (p=0.08) ( online supplemental figure S7H ).
← all excerpts
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC.
1
0.0800
0.0800